Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.
The market for IV ibuprofen for pain management is in its nascent stage. The world IV ibuprofen market was valued at $3.6 million in 2015, and is projected to reach $14.2 million by 2022, registering a CAGR of 20% during the forecast period. Advantages associated with IV ibuprofen such as rapid result and targeted drug delivery have resulted in the growth of this market.
Browse more detail information of IV Ibuprofen Market Research Report @ http://www.absolutereports.com/world-intravenous-iv-ibuprofen-market-opportunities-and-forecasts-2015-2022-10192816
Currently, Cumberland Pharmaceuticals Inc., is the only IV ibuprofen manufacturer in the market. The company has collaborated with the local/regional drug manufacturers to target new countries by getting product approvals.
The Key Companies Profiled In This IV Ibuprofen Market Research Report Are
- Cumberland Pharmaceuticals Inc.,
- Alveda Pharmaceuticals, Inc. (acquired by Teligent, Inc.),
- CSL Limited,
- Sandor Medicaids Pvt Ltd.,
- Soho Industri Pharmasi,
- Germin MED,
- Grifols S.A.,
- Harbin Gloria Pharmaceuticals Co., Ltd.,
- Al Nabeel International Ltd., and
- Laboratorios Valmorca, C.A.
Get Sample PDF of this report @ http://www.absolutereports.com/enquiry/request-sample/10192816
The world IV Ibuprofen market is segmented on the basis of indication, age group, and country. By indication, further sub-segments considered in this report include pain/inflammation and fever. The age groups considered are pediatrics and adults. The market is segmented into four countries namely Australia, Canada, South Korea, and the U.S.
List of Figures, Tables and Charts Available in World Intravenous (IV) Ibuprofen Market – Opportunities and Forecasts, 2015 – 2022
TABLE 1 WORLD IV IBUPROFEN MARKET, MODERATE SCENARIO, BY COUNTRY, 2022 2027 ($MILLION)
TABLE 2 WORLD IV IBUPROFEN MARKET, RAPID GROWTH SCENARIO, BY COUNTRY, 2022 2027 ($MILLION)
TABLE 3 WORLD IV IBUPROFEN MARKET, DIMINISHING GROWTH SCENARIO, BY COUNTRY, 2022 2027 ($MILLION)
TABLE 4 CLINICAL TRIALS – ANALGESICS
TABLE 5 GLOBAL INCIDENCES OF DISEASES
TABLE 6 WORLD IV IBUPROFEN MARKET BY AGE GROUP, 2015-2022 ($MILLION)
TABLE 7 WORLD PEDIATRIC IV IBUPROFEN MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 8 WORLD ADULT IV IBUPROFEN MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 9 WORLD PAIN IV IBUPROFEN MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 10 WORLD FEVER IV IBUPROFEN MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 11 WORLD IV IBUPROFEN MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 12 UNITED STATES: ACTUAL IV IBUPROFEN MARKET, 20152022 ($MILLION)
TABLE 13 CANADA: ACTUAL IV IBUPROFEN MARKET, 20152022 ($MILLION)
TABLE 14 AUSTRALIA: ACTUAL IV IBUPROFEN MARKET, 20152022 ($MILLION)
TABLE 15 SOUTH KOREA: ACTUAL IV IBUPROFEN MARKET, 20152022 ($MILLION)
TABLE 16 COMPANY SNAPSHOT OF CUMBERLAND PHARMACEUTICALS
TABLE 17 CUMBERLAND PHARMACEUTICALS OPERATING SEGMENTS
TABLE 18 COMPANY SNAPSHOT OF ALVEDA PHARMACEUTICALS, INC.
Need more details of this report @ http://www.absolutereports.com/enquiry/pre-order-enquiry/10192816
About Absolute Reports:
Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.
Mr. Ameya Pingaley
+1-408 520 9750
Get More Market Research Related News, visit @: www.marketresearch.news